Global Parenteral Formula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
According to our (Global Info Research) latest study, the global Parenteral Formula market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Parenteral Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Parenteral Formula market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parenteral Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parenteral Formula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co.,Ltd., Grifols, S.A., Aculife Healthcare Private Limited, Vifor Pharma Group, Terumo Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Parenteral Formula market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parenteral Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parenteral Formula, with price, sales quantity, revenue, and global market share of Parenteral Formula from 2019 to 2024.
Chapter 3, the Parenteral Formula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parenteral Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Parenteral Formula market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parenteral Formula.
Chapter 14 and 15, to describe Parenteral Formula sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Parenteral Formula market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Parenteral Formula market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Parenteral Formula market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Parenteral Formula market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parenteral Formula
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Parenteral Formula market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co.,Ltd., Grifols, S.A., Aculife Healthcare Private Limited, Vifor Pharma Group, Terumo Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Parenteral Formula market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Carbohydrates
- Amino Acids
- Lipids
- Electrolytes
- Vitamins and Minerals
- Specialty Formulas
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Baxter International lnc.
- B.Braun Melsungen AG
- Fresenius Kabi AG
- Hospira, Inc.
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Otsuka Pharmaceutical Co.,Ltd.
- Grifols, S.A.
- Aculife Healthcare Private Limited
- Vifor Pharma Group
- Terumo Corporation
- Nutricia
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parenteral Formula product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parenteral Formula, with price, sales quantity, revenue, and global market share of Parenteral Formula from 2019 to 2024.
Chapter 3, the Parenteral Formula competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parenteral Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Parenteral Formula market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parenteral Formula.
Chapter 14 and 15, to describe Parenteral Formula sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Parenteral Formula Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Carbohydrates
1.3.3 Amino Acids
1.3.4 Lipids
1.3.5 Electrolytes
1.3.6 Vitamins and Minerals
1.3.7 Specialty Formulas
1.4 Market Analysis by Application
1.4.1 Overview: Global Parenteral Formula Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Parenteral Formula Market Size & Forecast
1.5.1 Global Parenteral Formula Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Parenteral Formula Sales Quantity (2019-2030)
1.5.3 Global Parenteral Formula Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Baxter International lnc.
2.1.1 Baxter International lnc. Details
2.1.2 Baxter International lnc. Major Business
2.1.3 Baxter International lnc. Parenteral Formula Product and Services
2.1.4 Baxter International lnc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Baxter International lnc. Recent Developments/Updates
2.2 B.Braun Melsungen AG
2.2.1 B.Braun Melsungen AG Details
2.2.2 B.Braun Melsungen AG Major Business
2.2.3 B.Braun Melsungen AG Parenteral Formula Product and Services
2.2.4 B.Braun Melsungen AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 B.Braun Melsungen AG Recent Developments/Updates
2.3 Fresenius Kabi AG
2.3.1 Fresenius Kabi AG Details
2.3.2 Fresenius Kabi AG Major Business
2.3.3 Fresenius Kabi AG Parenteral Formula Product and Services
2.3.4 Fresenius Kabi AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Fresenius Kabi AG Recent Developments/Updates
2.4 Hospira, Inc.
2.4.1 Hospira, Inc. Details
2.4.2 Hospira, Inc. Major Business
2.4.3 Hospira, Inc. Parenteral Formula Product and Services
2.4.4 Hospira, Inc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hospira, Inc. Recent Developments/Updates
2.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
2.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Details
2.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Major Business
2.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
2.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.6 Otsuka Pharmaceutical Co.,Ltd.
2.6.1 Otsuka Pharmaceutical Co.,Ltd. Details
2.6.2 Otsuka Pharmaceutical Co.,Ltd. Major Business
2.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
2.6.4 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.7 Grifols, S.A.
2.7.1 Grifols, S.A. Details
2.7.2 Grifols, S.A. Major Business
2.7.3 Grifols, S.A. Parenteral Formula Product and Services
2.7.4 Grifols, S.A. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Grifols, S.A. Recent Developments/Updates
2.8 Aculife Healthcare Private Limited
2.8.1 Aculife Healthcare Private Limited Details
2.8.2 Aculife Healthcare Private Limited Major Business
2.8.3 Aculife Healthcare Private Limited Parenteral Formula Product and Services
2.8.4 Aculife Healthcare Private Limited Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Aculife Healthcare Private Limited Recent Developments/Updates
2.9 Vifor Pharma Group
2.9.1 Vifor Pharma Group Details
2.9.2 Vifor Pharma Group Major Business
2.9.3 Vifor Pharma Group Parenteral Formula Product and Services
2.9.4 Vifor Pharma Group Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vifor Pharma Group Recent Developments/Updates
2.10 Terumo Corporation
2.10.1 Terumo Corporation Details
2.10.2 Terumo Corporation Major Business
2.10.3 Terumo Corporation Parenteral Formula Product and Services
2.10.4 Terumo Corporation Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Terumo Corporation Recent Developments/Updates
2.11 Nutricia
2.11.1 Nutricia Details
2.11.2 Nutricia Major Business
2.11.3 Nutricia Parenteral Formula Product and Services
2.11.4 Nutricia Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Nutricia Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PARENTERAL FORMULA BY MANUFACTURER
3.1 Global Parenteral Formula Sales Quantity by Manufacturer (2019-2024)
3.2 Global Parenteral Formula Revenue by Manufacturer (2019-2024)
3.3 Global Parenteral Formula Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Parenteral Formula by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Parenteral Formula Manufacturer Market Share in 2023
3.4.3 Top 6 Parenteral Formula Manufacturer Market Share in 2023
3.5 Parenteral Formula Market: Overall Company Footprint Analysis
3.5.1 Parenteral Formula Market: Region Footprint
3.5.2 Parenteral Formula Market: Company Product Type Footprint
3.5.3 Parenteral Formula Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Parenteral Formula Market Size by Region
4.1.1 Global Parenteral Formula Sales Quantity by Region (2019-2030)
4.1.2 Global Parenteral Formula Consumption Value by Region (2019-2030)
4.1.3 Global Parenteral Formula Average Price by Region (2019-2030)
4.2 North America Parenteral Formula Consumption Value (2019-2030)
4.3 Europe Parenteral Formula Consumption Value (2019-2030)
4.4 Asia-Pacific Parenteral Formula Consumption Value (2019-2030)
4.5 South America Parenteral Formula Consumption Value (2019-2030)
4.6 Middle East & Africa Parenteral Formula Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Parenteral Formula Sales Quantity by Type (2019-2030)
5.2 Global Parenteral Formula Consumption Value by Type (2019-2030)
5.3 Global Parenteral Formula Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Parenteral Formula Sales Quantity by Application (2019-2030)
6.2 Global Parenteral Formula Consumption Value by Application (2019-2030)
6.3 Global Parenteral Formula Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Parenteral Formula Sales Quantity by Type (2019-2030)
7.2 North America Parenteral Formula Sales Quantity by Application (2019-2030)
7.3 North America Parenteral Formula Market Size by Country
7.3.1 North America Parenteral Formula Sales Quantity by Country (2019-2030)
7.3.2 North America Parenteral Formula Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Parenteral Formula Sales Quantity by Type (2019-2030)
8.2 Europe Parenteral Formula Sales Quantity by Application (2019-2030)
8.3 Europe Parenteral Formula Market Size by Country
8.3.1 Europe Parenteral Formula Sales Quantity by Country (2019-2030)
8.3.2 Europe Parenteral Formula Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Parenteral Formula Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Parenteral Formula Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Parenteral Formula Market Size by Region
9.3.1 Asia-Pacific Parenteral Formula Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Parenteral Formula Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Parenteral Formula Sales Quantity by Type (2019-2030)
10.2 South America Parenteral Formula Sales Quantity by Application (2019-2030)
10.3 South America Parenteral Formula Market Size by Country
10.3.1 South America Parenteral Formula Sales Quantity by Country (2019-2030)
10.3.2 South America Parenteral Formula Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Parenteral Formula Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Parenteral Formula Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Parenteral Formula Market Size by Country
11.3.1 Middle East & Africa Parenteral Formula Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Parenteral Formula Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Parenteral Formula Market Drivers
12.2 Parenteral Formula Market Restraints
12.3 Parenteral Formula Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Parenteral Formula and Key Manufacturers
13.2 Manufacturing Costs Percentage of Parenteral Formula
13.3 Parenteral Formula Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Parenteral Formula Typical Distributors
14.3 Parenteral Formula Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Parenteral Formula Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Carbohydrates
1.3.3 Amino Acids
1.3.4 Lipids
1.3.5 Electrolytes
1.3.6 Vitamins and Minerals
1.3.7 Specialty Formulas
1.4 Market Analysis by Application
1.4.1 Overview: Global Parenteral Formula Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Parenteral Formula Market Size & Forecast
1.5.1 Global Parenteral Formula Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Parenteral Formula Sales Quantity (2019-2030)
1.5.3 Global Parenteral Formula Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Baxter International lnc.
2.1.1 Baxter International lnc. Details
2.1.2 Baxter International lnc. Major Business
2.1.3 Baxter International lnc. Parenteral Formula Product and Services
2.1.4 Baxter International lnc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Baxter International lnc. Recent Developments/Updates
2.2 B.Braun Melsungen AG
2.2.1 B.Braun Melsungen AG Details
2.2.2 B.Braun Melsungen AG Major Business
2.2.3 B.Braun Melsungen AG Parenteral Formula Product and Services
2.2.4 B.Braun Melsungen AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 B.Braun Melsungen AG Recent Developments/Updates
2.3 Fresenius Kabi AG
2.3.1 Fresenius Kabi AG Details
2.3.2 Fresenius Kabi AG Major Business
2.3.3 Fresenius Kabi AG Parenteral Formula Product and Services
2.3.4 Fresenius Kabi AG Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Fresenius Kabi AG Recent Developments/Updates
2.4 Hospira, Inc.
2.4.1 Hospira, Inc. Details
2.4.2 Hospira, Inc. Major Business
2.4.3 Hospira, Inc. Parenteral Formula Product and Services
2.4.4 Hospira, Inc. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hospira, Inc. Recent Developments/Updates
2.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
2.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Details
2.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Major Business
2.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
2.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.6 Otsuka Pharmaceutical Co.,Ltd.
2.6.1 Otsuka Pharmaceutical Co.,Ltd. Details
2.6.2 Otsuka Pharmaceutical Co.,Ltd. Major Business
2.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
2.6.4 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
2.7 Grifols, S.A.
2.7.1 Grifols, S.A. Details
2.7.2 Grifols, S.A. Major Business
2.7.3 Grifols, S.A. Parenteral Formula Product and Services
2.7.4 Grifols, S.A. Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Grifols, S.A. Recent Developments/Updates
2.8 Aculife Healthcare Private Limited
2.8.1 Aculife Healthcare Private Limited Details
2.8.2 Aculife Healthcare Private Limited Major Business
2.8.3 Aculife Healthcare Private Limited Parenteral Formula Product and Services
2.8.4 Aculife Healthcare Private Limited Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Aculife Healthcare Private Limited Recent Developments/Updates
2.9 Vifor Pharma Group
2.9.1 Vifor Pharma Group Details
2.9.2 Vifor Pharma Group Major Business
2.9.3 Vifor Pharma Group Parenteral Formula Product and Services
2.9.4 Vifor Pharma Group Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vifor Pharma Group Recent Developments/Updates
2.10 Terumo Corporation
2.10.1 Terumo Corporation Details
2.10.2 Terumo Corporation Major Business
2.10.3 Terumo Corporation Parenteral Formula Product and Services
2.10.4 Terumo Corporation Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Terumo Corporation Recent Developments/Updates
2.11 Nutricia
2.11.1 Nutricia Details
2.11.2 Nutricia Major Business
2.11.3 Nutricia Parenteral Formula Product and Services
2.11.4 Nutricia Parenteral Formula Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Nutricia Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PARENTERAL FORMULA BY MANUFACTURER
3.1 Global Parenteral Formula Sales Quantity by Manufacturer (2019-2024)
3.2 Global Parenteral Formula Revenue by Manufacturer (2019-2024)
3.3 Global Parenteral Formula Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Parenteral Formula by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Parenteral Formula Manufacturer Market Share in 2023
3.4.3 Top 6 Parenteral Formula Manufacturer Market Share in 2023
3.5 Parenteral Formula Market: Overall Company Footprint Analysis
3.5.1 Parenteral Formula Market: Region Footprint
3.5.2 Parenteral Formula Market: Company Product Type Footprint
3.5.3 Parenteral Formula Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Parenteral Formula Market Size by Region
4.1.1 Global Parenteral Formula Sales Quantity by Region (2019-2030)
4.1.2 Global Parenteral Formula Consumption Value by Region (2019-2030)
4.1.3 Global Parenteral Formula Average Price by Region (2019-2030)
4.2 North America Parenteral Formula Consumption Value (2019-2030)
4.3 Europe Parenteral Formula Consumption Value (2019-2030)
4.4 Asia-Pacific Parenteral Formula Consumption Value (2019-2030)
4.5 South America Parenteral Formula Consumption Value (2019-2030)
4.6 Middle East & Africa Parenteral Formula Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Parenteral Formula Sales Quantity by Type (2019-2030)
5.2 Global Parenteral Formula Consumption Value by Type (2019-2030)
5.3 Global Parenteral Formula Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Parenteral Formula Sales Quantity by Application (2019-2030)
6.2 Global Parenteral Formula Consumption Value by Application (2019-2030)
6.3 Global Parenteral Formula Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Parenteral Formula Sales Quantity by Type (2019-2030)
7.2 North America Parenteral Formula Sales Quantity by Application (2019-2030)
7.3 North America Parenteral Formula Market Size by Country
7.3.1 North America Parenteral Formula Sales Quantity by Country (2019-2030)
7.3.2 North America Parenteral Formula Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Parenteral Formula Sales Quantity by Type (2019-2030)
8.2 Europe Parenteral Formula Sales Quantity by Application (2019-2030)
8.3 Europe Parenteral Formula Market Size by Country
8.3.1 Europe Parenteral Formula Sales Quantity by Country (2019-2030)
8.3.2 Europe Parenteral Formula Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Parenteral Formula Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Parenteral Formula Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Parenteral Formula Market Size by Region
9.3.1 Asia-Pacific Parenteral Formula Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Parenteral Formula Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Parenteral Formula Sales Quantity by Type (2019-2030)
10.2 South America Parenteral Formula Sales Quantity by Application (2019-2030)
10.3 South America Parenteral Formula Market Size by Country
10.3.1 South America Parenteral Formula Sales Quantity by Country (2019-2030)
10.3.2 South America Parenteral Formula Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Parenteral Formula Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Parenteral Formula Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Parenteral Formula Market Size by Country
11.3.1 Middle East & Africa Parenteral Formula Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Parenteral Formula Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Parenteral Formula Market Drivers
12.2 Parenteral Formula Market Restraints
12.3 Parenteral Formula Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Parenteral Formula and Key Manufacturers
13.2 Manufacturing Costs Percentage of Parenteral Formula
13.3 Parenteral Formula Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Parenteral Formula Typical Distributors
14.3 Parenteral Formula Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Parenteral Formula Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parenteral Formula Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Baxter International lnc. Basic Information, Manufacturing Base and Competitors
Table 4. Baxter International lnc. Major Business
Table 5. Baxter International lnc. Parenteral Formula Product and Services
Table 6. Baxter International lnc. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Baxter International lnc. Recent Developments/Updates
Table 8. B.Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 9. B.Braun Melsungen AG Major Business
Table 10. B.Braun Melsungen AG Parenteral Formula Product and Services
Table 11. B.Braun Melsungen AG Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. B.Braun Melsungen AG Recent Developments/Updates
Table 13. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi AG Major Business
Table 15. Fresenius Kabi AG Parenteral Formula Product and Services
Table 16. Fresenius Kabi AG Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Fresenius Kabi AG Recent Developments/Updates
Table 18. Hospira, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Hospira, Inc. Major Business
Table 20. Hospira, Inc. Parenteral Formula Product and Services
Table 21. Hospira, Inc. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Hospira, Inc. Recent Developments/Updates
Table 23. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Sichuan Kelun Pharmaceutical Co.,Ltd. Major Business
Table 25. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
Table 26. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 28. Otsuka Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Otsuka Pharmaceutical Co.,Ltd. Major Business
Table 30. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
Table 31. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 33. Grifols, S.A. Basic Information, Manufacturing Base and Competitors
Table 34. Grifols, S.A. Major Business
Table 35. Grifols, S.A. Parenteral Formula Product and Services
Table 36. Grifols, S.A. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Grifols, S.A. Recent Developments/Updates
Table 38. Aculife Healthcare Private Limited Basic Information, Manufacturing Base and Competitors
Table 39. Aculife Healthcare Private Limited Major Business
Table 40. Aculife Healthcare Private Limited Parenteral Formula Product and Services
Table 41. Aculife Healthcare Private Limited Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Aculife Healthcare Private Limited Recent Developments/Updates
Table 43. Vifor Pharma Group Basic Information, Manufacturing Base and Competitors
Table 44. Vifor Pharma Group Major Business
Table 45. Vifor Pharma Group Parenteral Formula Product and Services
Table 46. Vifor Pharma Group Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Vifor Pharma Group Recent Developments/Updates
Table 48. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Terumo Corporation Major Business
Table 50. Terumo Corporation Parenteral Formula Product and Services
Table 51. Terumo Corporation Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Terumo Corporation Recent Developments/Updates
Table 53. Nutricia Basic Information, Manufacturing Base and Competitors
Table 54. Nutricia Major Business
Table 55. Nutricia Parenteral Formula Product and Services
Table 56. Nutricia Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Nutricia Recent Developments/Updates
Table 58. Global Parenteral Formula Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Parenteral Formula Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Parenteral Formula Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Parenteral Formula, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 62. Head Office and Parenteral Formula Production Site of Key Manufacturer
Table 63. Parenteral Formula Market: Company Product Type Footprint
Table 64. Parenteral Formula Market: Company Product Application Footprint
Table 65. Parenteral Formula New Market Entrants and Barriers to Market Entry
Table 66. Parenteral Formula Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Parenteral Formula Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 68. Global Parenteral Formula Sales Quantity by Region (2019-2024) & (K Units)
Table 69. Global Parenteral Formula Sales Quantity by Region (2025-2030) & (K Units)
Table 70. Global Parenteral Formula Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Global Parenteral Formula Consumption Value by Region (2025-2030) & (USD Million)
Table 72. Global Parenteral Formula Average Price by Region (2019-2024) & (US$/Unit)
Table 73. Global Parenteral Formula Average Price by Region (2025-2030) & (US$/Unit)
Table 74. Global Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 75. Global Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 76. Global Parenteral Formula Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Global Parenteral Formula Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Global Parenteral Formula Average Price by Type (2019-2024) & (US$/Unit)
Table 79. Global Parenteral Formula Average Price by Type (2025-2030) & (US$/Unit)
Table 80. Global Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Global Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Global Parenteral Formula Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Global Parenteral Formula Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Global Parenteral Formula Average Price by Application (2019-2024) & (US$/Unit)
Table 85. Global Parenteral Formula Average Price by Application (2025-2030) & (US$/Unit)
Table 86. North America Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 87. North America Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 88. North America Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 89. North America Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 90. North America Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 91. North America Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 92. North America Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 95. Europe Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 96. Europe Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 97. Europe Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 98. Europe Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 99. Europe Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 100. Europe Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 101. Europe Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Asia-Pacific Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Asia-Pacific Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Asia-Pacific Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Asia-Pacific Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Asia-Pacific Parenteral Formula Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Asia-Pacific Parenteral Formula Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Asia-Pacific Parenteral Formula Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Asia-Pacific Parenteral Formula Consumption Value by Region (2025-2030) & (USD Million)
Table 110. South America Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 111. South America Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 112. South America Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 113. South America Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 114. South America Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 115. South America Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 116. South America Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Middle East & Africa Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Middle East & Africa Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Middle East & Africa Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Middle East & Africa Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Middle East & Africa Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Middle East & Africa Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Middle East & Africa Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Parenteral Formula Raw Material
Table 127. Key Manufacturers of Parenteral Formula Raw Materials
Table 128. Parenteral Formula Typical Distributors
Table 129. Parenteral Formula Typical Customers
Table 1. Global Parenteral Formula Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parenteral Formula Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Baxter International lnc. Basic Information, Manufacturing Base and Competitors
Table 4. Baxter International lnc. Major Business
Table 5. Baxter International lnc. Parenteral Formula Product and Services
Table 6. Baxter International lnc. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Baxter International lnc. Recent Developments/Updates
Table 8. B.Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 9. B.Braun Melsungen AG Major Business
Table 10. B.Braun Melsungen AG Parenteral Formula Product and Services
Table 11. B.Braun Melsungen AG Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. B.Braun Melsungen AG Recent Developments/Updates
Table 13. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi AG Major Business
Table 15. Fresenius Kabi AG Parenteral Formula Product and Services
Table 16. Fresenius Kabi AG Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Fresenius Kabi AG Recent Developments/Updates
Table 18. Hospira, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Hospira, Inc. Major Business
Table 20. Hospira, Inc. Parenteral Formula Product and Services
Table 21. Hospira, Inc. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Hospira, Inc. Recent Developments/Updates
Table 23. Sichuan Kelun Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Sichuan Kelun Pharmaceutical Co.,Ltd. Major Business
Table 25. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
Table 26. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 28. Otsuka Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Otsuka Pharmaceutical Co.,Ltd. Major Business
Table 30. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product and Services
Table 31. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 33. Grifols, S.A. Basic Information, Manufacturing Base and Competitors
Table 34. Grifols, S.A. Major Business
Table 35. Grifols, S.A. Parenteral Formula Product and Services
Table 36. Grifols, S.A. Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Grifols, S.A. Recent Developments/Updates
Table 38. Aculife Healthcare Private Limited Basic Information, Manufacturing Base and Competitors
Table 39. Aculife Healthcare Private Limited Major Business
Table 40. Aculife Healthcare Private Limited Parenteral Formula Product and Services
Table 41. Aculife Healthcare Private Limited Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Aculife Healthcare Private Limited Recent Developments/Updates
Table 43. Vifor Pharma Group Basic Information, Manufacturing Base and Competitors
Table 44. Vifor Pharma Group Major Business
Table 45. Vifor Pharma Group Parenteral Formula Product and Services
Table 46. Vifor Pharma Group Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Vifor Pharma Group Recent Developments/Updates
Table 48. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Terumo Corporation Major Business
Table 50. Terumo Corporation Parenteral Formula Product and Services
Table 51. Terumo Corporation Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Terumo Corporation Recent Developments/Updates
Table 53. Nutricia Basic Information, Manufacturing Base and Competitors
Table 54. Nutricia Major Business
Table 55. Nutricia Parenteral Formula Product and Services
Table 56. Nutricia Parenteral Formula Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Nutricia Recent Developments/Updates
Table 58. Global Parenteral Formula Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Parenteral Formula Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Parenteral Formula Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Parenteral Formula, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 62. Head Office and Parenteral Formula Production Site of Key Manufacturer
Table 63. Parenteral Formula Market: Company Product Type Footprint
Table 64. Parenteral Formula Market: Company Product Application Footprint
Table 65. Parenteral Formula New Market Entrants and Barriers to Market Entry
Table 66. Parenteral Formula Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Parenteral Formula Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 68. Global Parenteral Formula Sales Quantity by Region (2019-2024) & (K Units)
Table 69. Global Parenteral Formula Sales Quantity by Region (2025-2030) & (K Units)
Table 70. Global Parenteral Formula Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Global Parenteral Formula Consumption Value by Region (2025-2030) & (USD Million)
Table 72. Global Parenteral Formula Average Price by Region (2019-2024) & (US$/Unit)
Table 73. Global Parenteral Formula Average Price by Region (2025-2030) & (US$/Unit)
Table 74. Global Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 75. Global Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 76. Global Parenteral Formula Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Global Parenteral Formula Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Global Parenteral Formula Average Price by Type (2019-2024) & (US$/Unit)
Table 79. Global Parenteral Formula Average Price by Type (2025-2030) & (US$/Unit)
Table 80. Global Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Global Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Global Parenteral Formula Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Global Parenteral Formula Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Global Parenteral Formula Average Price by Application (2019-2024) & (US$/Unit)
Table 85. Global Parenteral Formula Average Price by Application (2025-2030) & (US$/Unit)
Table 86. North America Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 87. North America Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 88. North America Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 89. North America Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 90. North America Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 91. North America Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 92. North America Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 95. Europe Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 96. Europe Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 97. Europe Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 98. Europe Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 99. Europe Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 100. Europe Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 101. Europe Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Asia-Pacific Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Asia-Pacific Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Asia-Pacific Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Asia-Pacific Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Asia-Pacific Parenteral Formula Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Asia-Pacific Parenteral Formula Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Asia-Pacific Parenteral Formula Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Asia-Pacific Parenteral Formula Consumption Value by Region (2025-2030) & (USD Million)
Table 110. South America Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 111. South America Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 112. South America Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 113. South America Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 114. South America Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 115. South America Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 116. South America Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Parenteral Formula Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Middle East & Africa Parenteral Formula Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Middle East & Africa Parenteral Formula Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Middle East & Africa Parenteral Formula Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Middle East & Africa Parenteral Formula Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Middle East & Africa Parenteral Formula Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Middle East & Africa Parenteral Formula Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Middle East & Africa Parenteral Formula Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Parenteral Formula Raw Material
Table 127. Key Manufacturers of Parenteral Formula Raw Materials
Table 128. Parenteral Formula Typical Distributors
Table 129. Parenteral Formula Typical Customers
LIST OF FIGURES
Figure 1. Parenteral Formula Picture
Figure 2. Global Parenteral Formula Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parenteral Formula Revenue Market Share by Type in 2023
Figure 4. Carbohydrates Examples
Figure 5. Amino Acids Examples
Figure 6. Lipids Examples
Figure 7. Electrolytes Examples
Figure 8. Vitamins and Minerals Examples
Figure 9. Specialty Formulas Examples
Figure 10. Global Parenteral Formula Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Parenteral Formula Revenue Market Share by Application in 2023
Figure 12. Hospital Pharmacies Examples
Figure 13. Retail Pharmacies Examples
Figure 14. Online Pharmacies Examples
Figure 15. Global Parenteral Formula Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Parenteral Formula Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Parenteral Formula Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Parenteral Formula Price (2019-2030) & (US$/Unit)
Figure 19. Global Parenteral Formula Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Parenteral Formula Revenue Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Parenteral Formula by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 22. Top 3 Parenteral Formula Manufacturer (Revenue) Market Share in 2023
Figure 23. Top 6 Parenteral Formula Manufacturer (Revenue) Market Share in 2023
Figure 24. Global Parenteral Formula Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Parenteral Formula Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Parenteral Formula Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Parenteral Formula Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Parenteral Formula Revenue Market Share by Application (2019-2030)
Figure 36. Global Parenteral Formula Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 49. France Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 50. United Kingdom Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 51. Russia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 52. Italy Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Parenteral Formula Consumption Value Market Share by Region (2019-2030)
Figure 57. China Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 58. Japan Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 59. South Korea Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 60. India Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 61. Southeast Asia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 62. Australia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 63. South America Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 68. Argentina Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 72. Middle East & Africa Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 73. Turkey Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 74. Egypt Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 76. South Africa Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 77. Parenteral Formula Market Drivers
Figure 78. Parenteral Formula Market Restraints
Figure 79. Parenteral Formula Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Parenteral Formula in 2023
Figure 82. Manufacturing Process Analysis of Parenteral Formula
Figure 83. Parenteral Formula Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Parenteral Formula Picture
Figure 2. Global Parenteral Formula Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parenteral Formula Revenue Market Share by Type in 2023
Figure 4. Carbohydrates Examples
Figure 5. Amino Acids Examples
Figure 6. Lipids Examples
Figure 7. Electrolytes Examples
Figure 8. Vitamins and Minerals Examples
Figure 9. Specialty Formulas Examples
Figure 10. Global Parenteral Formula Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Parenteral Formula Revenue Market Share by Application in 2023
Figure 12. Hospital Pharmacies Examples
Figure 13. Retail Pharmacies Examples
Figure 14. Online Pharmacies Examples
Figure 15. Global Parenteral Formula Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Parenteral Formula Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Parenteral Formula Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Parenteral Formula Price (2019-2030) & (US$/Unit)
Figure 19. Global Parenteral Formula Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Parenteral Formula Revenue Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Parenteral Formula by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 22. Top 3 Parenteral Formula Manufacturer (Revenue) Market Share in 2023
Figure 23. Top 6 Parenteral Formula Manufacturer (Revenue) Market Share in 2023
Figure 24. Global Parenteral Formula Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Parenteral Formula Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Parenteral Formula Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Parenteral Formula Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Parenteral Formula Revenue Market Share by Application (2019-2030)
Figure 36. Global Parenteral Formula Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 49. France Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 50. United Kingdom Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 51. Russia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 52. Italy Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Parenteral Formula Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Parenteral Formula Consumption Value Market Share by Region (2019-2030)
Figure 57. China Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 58. Japan Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 59. South Korea Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 60. India Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 61. Southeast Asia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 62. Australia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 63. South America Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 68. Argentina Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Parenteral Formula Sales Quantity Market Share by Country (2019-2030)
Figure 72. Middle East & Africa Parenteral Formula Consumption Value Market Share by Country (2019-2030)
Figure 73. Turkey Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 74. Egypt Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 76. South Africa Parenteral Formula Consumption Value (2019-2030) & (USD Million)
Figure 77. Parenteral Formula Market Drivers
Figure 78. Parenteral Formula Market Restraints
Figure 79. Parenteral Formula Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Parenteral Formula in 2023
Figure 82. Manufacturing Process Analysis of Parenteral Formula
Figure 83. Parenteral Formula Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
